Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitions.
Mande G, Akonda I, De Weggheleire A, Brosius I, Liesenborghs L, Bottieau E, Ross N, Gembu GC, Colebunders R, Verheyen E, Ngonda D, Leirs H, Laudisoit A. Mande G, et al. Among authors: liesenborghs l. Int J Infect Dis. 2022 Sep;122:647-655. doi: 10.1016/j.ijid.2022.06.060. Epub 2022 Jul 7. Int J Infect Dis. 2022. PMID: 35809857 Free PMC article.
Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.
De Baetselier I, Van Dijck C, Kenyon C, Coppens J, Michiels J, de Block T, Smet H, Coppens S, Vanroye F, Bugert JJ, Girl P, Zange S, Liesenborghs L, Brosius I, van Griensven J, Selhorst P, Florence E, Van den Bossche D, Ariën KK, Rezende AM, Vercauteren K, Van Esbroeck M; ITM Monkeypox study group. De Baetselier I, et al. Among authors: liesenborghs l. Nat Med. 2022 Nov;28(11):2288-2292. doi: 10.1038/s41591-022-02004-w. Epub 2022 Aug 12. Nat Med. 2022. PMID: 35961373 Free PMC article.
Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort study.
Brosius I, Van Dijck C, Coppens J, Vandenhove L, Bangwen E, Vanroye F, Verschueren J; ITM MPOX Study Group; Zange S, Bugert J, Michiels J, Bottieau E, Soentjens P, van Griensven J, Kenyon C, Ariën KK, Van Esbroeck M, Vercauteren K, Liesenborghs L. Brosius I, et al. Among authors: liesenborghs l. J Med Virol. 2023 May;95(5):e28769. doi: 10.1002/jmv.28769. J Med Virol. 2023. PMID: 37212312
Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding.
Mertes H, Rezende AM, Brosius I, Naesens R, Michiels J, deBlock T, Coppens J, Van Dijck C, Bomans P, Bottieau E, Van Esbroeck M, Ariën KK, Liesenborghs L, Vercauteren K. Mertes H, et al. Among authors: liesenborghs l. Ann Intern Med. 2023 Aug;176(8):1141-1143. doi: 10.7326/L23-0131. Epub 2023 Jul 25. Ann Intern Med. 2023. PMID: 37487213 Free article. No abstract available.
Detection of mpox virus in ambient air in a sexual health clinic.
Raymenants J, Van Gestel L, Coppens J, De Block T, Bangwen E, Rutgers J, Hens M, De Vos E, Coppens S, Keyaerts E, André E, Rezende AM, Van Esbroeck M, Vercauteren K, Liesenborghs L. Raymenants J, et al. Among authors: liesenborghs l. Arch Virol. 2023 Jul 24;168(8):210. doi: 10.1007/s00705-023-05837-z. Arch Virol. 2023. PMID: 37486383 Free PMC article.
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
Devos T, Geukens T, Schauwvlieghe A, Ariën KK, Barbezange C, Cleeren M, Compernolle V, Dauby N, Desmecht D, Grimaldi D, Lambrecht BN, Luyten A, Maes P, Moutschen M, Romano M, Seyler L, Nevessignsky MT, Vandenberghe K, van Griensven J, Verbeke G, Vlieghe E, Yombi JC, Liesenborghs L, Verhamme P, Meyfroidt G. Devos T, et al. Among authors: liesenborghs l. Trials. 2020 Nov 27;21(1):981. doi: 10.1186/s13063-020-04876-0. Trials. 2020. PMID: 33246499 Free PMC article. Clinical Trial.
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
Devos T, Geukens T, Schauwvlieghe A, Ariën KK, Barbezange C, Cleeren M, Compernolle V, Dauby N, Desmecht D, Grimaldi D, Lambrecht BN, Luyten A, Maes P, Moutschen M, Romano M, Seyler L, Nevessignsky MT, Vandenberghe K, van Griensven J, Verbeke G, Vlieghe E, Yombi JC, Liesenborghs L, Verhamme P, Meyfroidt G. Devos T, et al. Among authors: liesenborghs l. Trials. 2020 Dec 14;21(1):1024. doi: 10.1186/s13063-020-04947-2. Trials. 2020. PMID: 33317581 Free PMC article. No abstract available.
Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?
Abdela SG, Liesenborghs L, Tadese F, Abegaz SH, Bayuh FB, Asmamaw EA, Mebrate TA, Mamo AE, Embiale W, Hunegnaw S, Hundie DB, Hurissa Z, Agero G, Kaso AW, Mebrate MA, van Henten S, van Griensven J. Abdela SG, et al. Among authors: liesenborghs l. Am J Trop Med Hyg. 2021 Oct 29;105(6):1519-1520. doi: 10.4269/ajtmh.21-0603. Am J Trop Med Hyg. 2021. PMID: 34715676 Free PMC article.
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
Sanchez-Felipe L, Vercruysse T, Sharma S, Ma J, Lemmens V, Van Looveren D, Arkalagud Javarappa MP, Boudewijns R, Malengier-Devlies B, Liesenborghs L, Kaptein SJF, De Keyzer C, Bervoets L, Debaveye S, Rasulova M, Seldeslachts L, Li LH, Jansen S, Yakass MB, Verstrepen BE, Böszörményi KP, Kiemenyi-Kayere G, van Driel N, Quaye O, Zhang X, Ter Horst S, Mishra N, Deboutte W, Matthijnssens J, Coelmont L, Vandermeulen C, Heylen E, Vergote V, Schols D, Wang Z, Bogers W, Kuiken T, Verschoor E, Cawthorne C, Van Laere K, Opdenakker G, Vande Velde G, Weynand B, Teuwen DE, Matthys P, Neyts J, Jan Thibaut H, Dallmeier K. Sanchez-Felipe L, et al. Among authors: liesenborghs l. Nature. 2021 Feb;590(7845):320-325. doi: 10.1038/s41586-020-3035-9. Epub 2020 Dec 1. Nature. 2021. PMID: 33260195
73 results